JD Health

Initially led by CEO Lijun Xin, who was instrumental in building the business from its inception, the leadership transitioned in September 2021. Jin Enlin, who joined JD.com in 2014 and has extensive experience in the medical and TMT sectors, was appointed as the new CEO. The company is chaired by Liu Qiangdong, the founder of JD.com.

JD Health's business model is multifaceted, operating across B2C, B2B, and O2O channels. A primary revenue stream is its retail pharmacy business, which includes both direct sales and a third-party marketplace. This platform offers a vast selection of pharmaceuticals, healthcare products, medical devices, and nutritional supplements. Leveraging JD.com's formidable supply chain, the company provides efficient delivery, including a 30-minute option in many cities through partnerships with over 200,000 offline pharmacies. The online healthcare services segment represents another core component of its operations. This includes telemedicine consultations with a network of over 130,000 doctors and medical professionals. During the COVID-19 pandemic, daily online consultations surged, reaching over 100,000. The company serves individual consumers, corporate clients, and medical institutions. It also provides digital solutions for corporations and insurance companies.

The company's offerings are designed to cover the entire lifecycle of a user's health needs. Services include online appointments for health check-ups, vaccinations, and medical cosmetology. JD Health has also established 16 specialized online medical centers focusing on areas like respiratory health and diabetes. Furthermore, it has developed intelligent hospital solutions and is a significant retailer of Food for Special Medical Purposes (FSMP). The company continually integrates technology, such as AI-driven customer service and data analytics, to enhance its services and personalize the user experience.